Fоrtikarb® 10% for the treatment of pyroplasmidosis in small ruminants

Abstract

Relevance. Piroplasmidoses cause significant economic damage to sheep breeding in the Republic of Dagestan, which consists of losses due to mortality, forced slaughter of animals and a decrease in meat and wool productivity. At present, to combat pyroplasmidosis diseases in sheep and goats, domestic and foreign researchers have proposed a number of medicinal preparations with therapeutic and prophylactic efficacy, but not all of them give the desired result. In In this regard, further improvement of existing methods and means of treating sheep is urgent.

Material and methods. The study of this issue was carried out taking into account the epizootic situation, clinical signs and microscopy of peripheral blood smears from sick animals (sheep of the Dagestan mountain breed). The work was carried out during the season of parasitism of ixodid ticks and the circulation of blood parasites in them from May to July 2020 through periodic visits to dysfunctional farms to examine and identify sick animals with  clinical signs of pyroplasmidosis. In order to study the species composition of ixodid ticks, which parasitize animals and can be carriers of piroplasmosis, arthropods were collected from animals according to the method of academician E.N. Pavlovsky. The drugs were tested on twenty heads, small ruminants, spontaneously infested with
piroplasmosis, which were divided according to the principle of analogues into two groups, exrimental and copentrol, ten heads each.

Results. Forticarb® in the form of a 10% solution for injection at a dose of 0.005 mg/kg of live weight, intramuscularly, at the rate of 0.5 ml per 10 kg of live body weight, has a high therapeutic efficacy in the treatment of pyroplasmidosis in small ruminants.